3Q 2022 Disruptor Series: The Future of Energy
Richard A. Brink is a Senior Vice President and Market Strategist in the Client Group. Previously, he served as a managing director in the Alternatives and Multi-Asset Group. Prior to that role, Brink was a senior portfolio manager in Fixed Income, and before that an investment director for fixed-income investments within the Global Retail Investments Group. Before joining AB in 2004, he was senior product manager at the Dreyfus Corporation, covering both retail and institutional fixed-income offerings. Brink was previously a senior trainer, dealing primarily with the design and delivery of product training to financial advisors and mutual fund sales representatives. He holds a BS in applied mathematics and economics from Stony Brook University, and is a CFA charterholder. Location: New York
Bob Brackett is a Managing Director and Senior Research Analyst covering North American oil and gas exploration and production (E&P). According to Institutional Investor's buy-side survey, as of 2015 he was the number-one analyst for this sector for the third year running. Previously, Brackett was director of E&P planning and director of corporate strategy for the Hess Corporation. Before Hess, he was an engagement manager with McKinsey & Company's petroleum practice, serving most of the world's largest oil companies across five continents and 30 countries. Brackett began his career with ExxonMobil, spending eight years in exploration, business development, and development and research. He holds a BS in geophysics and a BA in astronomy from the University of Texas, an MBA from Rice University and, as a NASA space grant fellow, a PhD in earth and planetary sciences from Washington University in St. Louis. Location: New York
More For You
Game-changing developments are reshaping healthcare and investment opportunities.
Healthcare is undergoing a profound transformation driven by groundbreaking advancements in technology, data and medicine. From predictive analytics and AI-enhanced diagnostics to precision treatments and robotics, these innovations are revolutionizing patient care. Our latest AB Disruptor Series installment examines how the healthcare industry has evolved through three lenses: pre-diagnosis, diagnosis and treatment. We’ll highlight advances reshaping this “lifecycle of healthcare.” And we’ll offer a forward perspective on what these changes mean for all of us—as patients and investors.
In our latest AB Disruptor Series episode, we take a closer look at the implications of a polarized US electorate on the macro and market landscape.